Total Payments
$19,015
2024 Payments
$2,867
Companies
44
Transactions
724
Medicare Patients
13,100
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$18,838 (99.1%)
Education$176.85 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,838 | 712 | 99.1% |
| Education | $176.85 | 12 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $2,465 | 75 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $2,454 | 100 | $0 (2024) |
| Amgen Inc. | $1,853 | 57 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,290 | 94 | $0 (2024) |
| Abbott Laboratories | $1,080 | 24 | $0 (2024) |
| PFIZER INC. | $976.44 | 49 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $936.48 | 40 | $0 (2024) |
| HEARTFLOW, INC. | $841.67 | 13 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $818.61 | 30 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $786.71 | 42 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,867 | 110 | Actelion Pharmaceuticals US, Inc. ($601.37) |
| 2023 | $3,488 | 114 | Actelion Pharmaceuticals US, Inc. ($600.52) |
| 2022 | $2,989 | 113 | Actelion Pharmaceuticals US, Inc. ($581.33) |
| 2021 | $1,905 | 97 | Actelion Pharmaceuticals US, Inc. ($270.72) |
| 2020 | $1,317 | 65 | Janssen Pharmaceuticals, Inc ($239.01) |
| 2019 | $2,434 | 75 | Janssen Pharmaceuticals, Inc ($435.35) |
| 2018 | $2,045 | 71 | Janssen Pharmaceuticals, Inc ($384.18) |
| 2017 | $1,969 | 79 | Amgen Inc. ($395.95) |
All Payment Transactions
724 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $40.61 | General |
| Category: Cardiology | ||||||
| 12/06/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.89 | General |
| Category: Cardiovascular | ||||||
| 12/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $31.85 | General |
| Category: Obesity | ||||||
| 12/02/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $30.36 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/25/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.94 | General |
| Category: Cardiovascular | ||||||
| 11/11/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $37.23 | General |
| Category: Cardiology | ||||||
| 11/05/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/04/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Cardio-renal | ||||||
| 10/29/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $34.92 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/28/2024 | AGEPHA Pharma FZ LLC | LODOCO (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Cardiovascular Diseases | ||||||
| 10/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: DIABETES | ||||||
| 10/21/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $29.43 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $55.10 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/14/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $37.23 | General |
| Category: Cardiology | ||||||
| 10/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Cardiology | ||||||
| 10/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Obesity | ||||||
| 09/24/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $33.75 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/18/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/16/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $31.86 | General |
| Category: Cardiology | ||||||
| 09/13/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $37.56 | General |
| Category: Not Applicable | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 3,655 | 6,062 | $1.1M | $405,578 |
| 2022 | 31 | 3,478 | 6,096 | $961,006 | $374,173 |
| 2021 | 31 | 3,082 | 5,676 | $887,591 | $348,093 |
| 2020 | 29 | 2,885 | 5,390 | $868,518 | $310,364 |
Total Patients
13,100
Total Services
23,224
Medicare Billing
$1.4M
Procedure Codes
130
All Medicare Procedures & Services
130 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 592 | 1,030 | $222,501 | $99,720 | 44.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 408 | 432 | $209,339 | $61,077 | 29.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 263 | 358 | $104,106 | $49,712 | 47.8% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 70 | 139 | $31,039 | $24,904 | 80.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 70 | 70 | $69,763 | $24,350 | 34.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 128 | 128 | $53,901 | $20,103 | 37.3% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 30 | 30 | $51,088 | $19,414 | 38.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 125 | 126 | $65,938 | $18,830 | 28.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 723 | 1,113 | $46,768 | $12,374 | 26.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 126 | 140 | $20,440 | $9,863 | 48.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 43 | 89 | $18,727 | $8,872 | 47.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 79 | 88 | $19,010 | $8,569 | 45.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 54 | 59 | $24,443 | $8,446 | 34.6% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 32 | 32 | $16,532 | $5,508 | 33.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $12,566 | $4,456 | 35.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 76 | 79 | $9,647 | $4,286 | 44.4% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 75 | 83 | $7,294 | $3,623 | 49.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 71 | 71 | $13,668 | $3,552 | 26.0% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 18 | 18 | $9,176 | $2,408 | 26.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 254 | 352 | $5,690 | $2,297 | 40.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 33 | $4,818 | $2,026 | 42.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 27 | $3,949 | $1,789 | 45.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 30 | 30 | $2,636 | $1,264 | 47.9% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 30 | 30 | $3,000 | $1,244 | 41.5% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 14 | 15 | $3,899 | $1,121 | 28.7% |
About Dr. David Steiman, M.D
Dr. David Steiman, M.D is a Cardiovascular Disease healthcare provider based in Plantation, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619084456.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Steiman, M.D has received a total of $19,015 in payments from pharmaceutical and medical device companies, with $2,867 received in 2024. These payments were reported across 724 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($18,838).
As a Medicare-enrolled provider, Steiman has provided services to 13,100 Medicare beneficiaries, totaling 23,224 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 130 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Plantation, FL
- Active Since 08/25/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1619084456
Products in Payments
- XARELTO (Drug) $2,439
- UPTRAVI (Drug) $1,949
- Repatha (Biological) $1,454
- ELIQUIS (Drug) $1,345
- ENTRESTO (Drug) $1,009
- FFRct (Device) $841.67
- JARDIANCE (Drug) $594.80
- FARXIGA (Drug) $578.04
- Vascepa (Drug) $536.62
- PRALUENT (Drug) $476.23
- Kerendia (Drug) $455.17
- Corlanor (Drug) $398.70
- OPSUMIT (Drug) $339.41
- PRALUENT ALIROCUMAB INJECTION (Biological) $310.38
- Ozempic (Drug) $302.10
- Barostim Neo System (Device) $286.72
- LEQVIO (Drug) $281.35
- WATCHMAN FLX (Device) $265.56
- VERQUVO (Drug) $233.79
- BRILINTA (Drug) $208.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Plantation
Dr. Robert Singal, Md, MD
Cardiovascular Disease — Payments: $107,811
Cardiovascular Disease $107,811
Kathir Selvan Subramanian, Md, MD
Cardiovascular Disease — Payments: $46,612
Cardiovascular Disease $46,612
Craig Hostig, Md, MD
Cardiovascular Disease — Payments: $18,606
Cardiovascular Disease $18,606
Jose Soler, Md, Facc, MD, FACC
Cardiovascular Disease — Payments: $16,803
Cardiovascular Disease $16,803
Arnold Ghitis, Md, MD
Cardiovascular Disease — Payments: $13,378
Cardiovascular Disease $13,378
Mr. Frederick Chaleff, Md, MD
Cardiovascular Disease — Payments: $12,578
Cardiovascular Disease $12,578